Nicotine Replacement Therapy  s market

Nicotine Replacement Therapy (NRT) Products Market, Global Outlook and Forecast 2022-2028

  • 12 July 2022
  • Life Sciences
  • 72 Pages
  • Report code : PMR-7202593

  • 4.7 (158)

Nicotine Replacement Therapy s Market

Download FREE Report Sample

  Download Free sample

Nicotine replacement therapy (NRT) is a medically-approved way to take nicotine by means other than tobacco. It is used to help with quitting smoking or stopping chewing tobacco. It increases the chance of quitting smoking by about 50% to 70%.Often it is used along with other behavioral techniques. NRT has also been used to treat ulcerative colitis. Types of NRT include the adhesive patch, chewing gum, lozenges, nose spray, and inhaler. The use of more than one type of NRT at a time may increase effectiveness.
Nicotine Replacement Therapy s Market contains market size and forecasts of Nicotine Replacement Therapy (NRT) Products in global, including the following market information:
Global Nicotine Replacement Therapy (NRT) Products Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nicotine Replacement Therapy (NRT) Products Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Nicotine Replacement Therapy (NRT) Products companies in 2021 (%)
The global Nicotine Replacement Therapy (NRT) Products market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sprays Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nicotine Replacement Therapy (NRT) Products include GSK, Perrigo Company, Pfizer, Fertin Pharma, Revolymer, Johnson & Johnson, Cambrex Corporation, Reynolds American and Dr. Reddy?s Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nicotine Replacement Therapy (NRT) Products manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nicotine Replacement Therapy (NRT) Products Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nicotine Replacement Therapy (NRT) Products Market Segment Percentages, by Type, 2021 (%)
Sprays
Inhalers
Chewing Gums
Transdermal Patches
Others
Global Nicotine Replacement Therapy (NRT) Products Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nicotine Replacement Therapy (NRT) Products Market Segment Percentages, by Application, 2021 (%)
Individual
Hospital
Withdrawal Clinics
Others
Global Nicotine Replacement Therapy (NRT) Products Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nicotine Replacement Therapy (NRT) Products Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nicotine Replacement Therapy (NRT) Products revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nicotine Replacement Therapy (NRT) Products revenues share in global market, 2021 (%)
Key companies Nicotine Replacement Therapy (NRT) Products sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Nicotine Replacement Therapy (NRT) Products sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Perrigo Company
Pfizer
Fertin Pharma
Revolymer
Johnson & Johnson
Cambrex Corporation
Reynolds American
Dr. Reddy?s Laboratories
Strides Consumer Private Limited
Kind Consumer
MicromistNOW

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Nicotine Replacement Therapy s Market

Leave This Empty: